Alector (ALEC) Enterprise Value (2018 - 2026)
Alector (ALEC) posted quarterly Enterprise Value of -$206.5 million for Q1 2026, up 41.75% year-over-year from -$145.7 million in Q1 2025, and up 19.34% quarter-over-quarter from -$256.0 million in Q4 2025.
Alector (ALEC) Enterprise Value (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Enterprise Value for 9 consecutive years, with -$206.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 41.75% year-over-year to -$206.5 million; the TTM figure through Mar 2026 stood at -$206.5 million (up 41.75% YoY), while the FY2025 annual figure was -$256.0 million, up 38.07% from the prior year.
- Enterprise Value improved to -$206.5 million in Q1 2026 per ALEC's latest filing, from -$256.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$206.5 million in Q1 2026 and bottomed at -$868.6 million in Q1 2022.
- Historically, Enterprise Value has averaged -$525.7 million across 5 years, with a median of -$548.9 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 153.11% — and 2026, when it surged 41.75%.
- Alector's Enterprise Value stood at -$712.9 million in 2022, then grew by 23.0% to -$548.9 million in 2023, then grew by 24.68% to -$413.4 million in 2024, then surged by 38.07% to -$256.0 million in 2025, then gained by 19.34% to -$206.5 million in 2026.
- Business Quant data shows ALEC's Enterprise Value at -$206.5 million in Q1 2026, -$256.0 million in Q4 2025, and -$291.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -172.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -172.80 Mn |
| Mar 31, 2026 | -206.52 Mn |
| Dec 31, 2025 | -256.02 Mn |
| Sep 30, 2025 | -291.11 Mn |
| Jun 30, 2025 | -307.28 Mn |
| Mar 31, 2025 | -354.55 Mn |
| Dec 31, 2024 | -413.40 Mn |
| Sep 30, 2024 | -457.20 Mn |
| Jun 30, 2024 | -503.33 Mn |
| Mar 31, 2024 | -562.08 Mn |
| Dec 31, 2023 | -548.86 Mn |
| Sep 30, 2023 | -588.86 Mn |
| Jun 30, 2023 | -630.05 Mn |
| Mar 31, 2023 | -669.33 Mn |
| Dec 31, 2022 | -712.85 Mn |
| Sep 30, 2022 | -758.31 Mn |
| Jun 30, 2022 | -808.86 Mn |
| Mar 31, 2022 | -868.57 Mn |
| Dec 31, 2021 | -735.25 Mn |
| Sep 30, 2021 | -777.85 Mn |